To cite this paper use one of the standards below:
Breast cancer is the most commonly occurring cancer in women. Leukemia was the sixth most common cause of cancer deaths.1 In addition, resistance to chemotherapy poses additional challenges to drug design. Flavonoid compounds display diverse biological activities such as antioxidant, anticancer and anti-inflammatory activities.2 The aim of this work was to design and synthesize carba-isoflavanone analogues, evaluate their in silico properties and antineoplastic activities. The synthesis was performed by palladium catalyzed α-arylation of α-tetralones and α-fluoro-tetralones with moderate to good yields up to 92%. Theoretical calculations predicted favorable physicochemical properties and low toxicity risks. The molecules were evaluated on cell lines with profiles of drug resistance, two breast cancers and three chronic myeloid leukemias, and compared to a non-tumor cell line. Results were promising for Lu45, Lu44, Lu48 and Lu47 (IC50= 36.37±2.05µM; 34.62±1.73µM; 29.50±1.51µM; 27.06±1.28µM, respectively) in FEPS cell line, a multidrug resistant leukemia cell.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper